Our Aim
Put India on the global stage for veterinary stem cell treatments.
CellMed is at the forefront of veterinary care with the introduction of stem cell therapy for canines. This is a significant development in pet healthcare. The application of veterinary stem cell therapy not only ushers in a new era but also aligns India with ongoing global treatments to provide optimal care for our cherished four-legged companions.
Know More
In treating veterinary conditions, CellMed introduces a breakthrough with stem cell-derived regenerative treatments, empowering veterinarians to enhance the quality of life for their animal patients. This compassionate approach goes beyond symptom management, providing an optimistic avenue for lasting improvements.
Read More
Stem cell therapy holds potential in treating prevalent canine joint issues, such as osteoarthritis and spinal injuries. Veterinary-guided intervention is essential for timely and effective treatment. Goals encompass reducing inflammation, supporting cartilage, enhancing mobility, promoting tissue regeneration, and ultimately improving a dog's overall quality of life.
Read More
MSC bioactive components offer potential benefits for various challenging wounds, including atopic dermatitis, chronic wounds, and autoimmune skin disorders in dogs. Target goals involve enhancing skin regeneration, accelerating wound closure, reducing inflammation and discomfort, preventing recurrence, and promoting long-term skin health.
Read More
MSC-Bioactive therapy, administered intravenously, stimulates immunomodulation, revitalizing cells and preventing aging signs. Primary goals include strengthening the immune system, addressing age-related inflammation, supporting joints, improving neurodegenerative conditions, boosting energy, preventing age-related diseases, and extending lifespan.
Read More
MSC Bioactive Component therapy shows promise in treating canine Keratoconjunctivitis Sicca (Dry Eye) by employing anti-inflammatory, regenerative, and neuroprotective mechanisms. It regulates immune responses, potentially benefiting secondary conditions like corneal ulcers, corneal dystrophy, glaucoma, and retinal diseases.
Read More
Mesenchymal stem cell (MSC) therapy holds potential for treating various nerve-related conditions in dogs, including peripheral neuropathy, intervertebral disc disease (IVDD), degenerative myelopathy, brachial plexus injury, and peripheral nerve injuries. Target goals involve improving motor and sensory functions, reducing pain.
Read More
Mesenchymal stem cells (MSCs) are considered for treating heart, liver, and kidney conditions in dogs, with decisions based on individual factors and condition severity. Target goals involve cardiac repair, liver function support, and kidney tissue regeneration. While MSC therapy may not guarantee complete organ cure, it shows potential in slowing disease progression.
Read MoreAt CellMed we are concentrating to improve the quality of life for Canine by treating conditions that presently have limited options and restricted benefits. These include organ repair, wound healing, immunomodolisation, dry eyes, nerve and orthopedic conditions. Prior to release of vials for compassionate use under veterinarian guidance, rigorous quality control measures are implemented. These measures aim to uphold the highest standards and include thorough scrutiny of the product’s safety and efficacy.
Read More
Put India on the global stage for veterinary stem cell treatments.
Enhance animal wellness with stem cell technology.
Collaborate with Veterinary Universities, Research Institutions, and Veterinarians to offer effective and affordable treatment options.